SPY312.19-2.65 -0.84%
DIA260.47-0.57 -0.22%
IXIC10,225.39-165.46 -1.59%

Credit Suisse Maintains Outperform on United Therapeutics, Raises Price Target to $145

Credit Suisse analyst Martin Auster maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target from $129 to $145.

Benzinga · -
Credit Suisse analyst Martin Auster maintains United Therapeutics (NASDAQ: UTHR) with a Outperform and raises the price target from $129 to $145.